×
Arcturus Therapeutics is a global late-stage clinical messenger RNA medicines and vaccines company focused on the discovery, development and ...
Arcturus Therapeutics

Arcturus Therapeutics

生物技術公司
收益2100 萬美元
執行長約瑟·E·佩恩 (2018 年 5 月 31 日–)
創立於2013 年
總經理約瑟·E·佩恩
資料來源: 標普智匯

相關問題
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases.
2023年10月26日 · Arcturus Therapeutics | 12448 followers on LinkedIn. A global mRNA medicines and vaccines company | Founded in 2013 and based in San Diego, ...
Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease ...
Arcturus Therapeutics is a global late-stage clinical messenger RNA medicines and vaccines company focused on the discovery, development and commercialization ...
2024年2月5日 · Arcturus' pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase deficiency and cystic fibrosis, along ...
The company's aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a ...